Anabolic Androgenic Steroids and Performance-Enhancing Drugs: Forensic Aspects, Collateral Effects, and Polypharmacy
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".
Deadline for manuscript submissions: closed (25 September 2024) | Viewed by 208
Special Issue Editor
Interests: forensic sciences; forensic imaging; forensic toxicology; pharmacogenetics; forensic pathology; public health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The use of anabolic androgenic steroids and performance-enhancing drugs is an increasingly current and evolving topic. More and more young people are using and accessing these drugs, and sometimes abusing them. There is also an easily accessible and poorly controlled black market. The side effects are multiple and multisystemic, even unknown.
As the Guest Editor, I would like to encourage you to submit research articles or comprehensive reviews or case reports to offer an overview of the use and side effects of anabolic androgenic steroids and performance-enhancing drugs, even in polypharmacy.
Dr. Massimiliano Esposito
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anabolic androgenic steroids
- doping drugs
- performance-enhancing drugs
- smart drugs
- forensic aspects
- polypharmacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
